117 related articles for article (PubMed ID: 6452036)
21. Approach to patients with degenerative disorders of the nervous system.
Walshe T
Gerodontics; 1988 Aug; 4(4):156-7. PubMed ID: 2978566
[No Abstract] [Full Text] [Related]
22. Transgenic mouse models of dopamine deficiency.
Chen L; Zhuang X
Ann Neurol; 2003; 54 Suppl 6():S91-102. PubMed ID: 12891659
[TBL] [Abstract][Full Text] [Related]
23. Animal models of neurological deficits: how relevant is the rat?
Cenci MA; Whishaw IQ; Schallert T
Nat Rev Neurosci; 2002 Jul; 3(7):574-9. PubMed ID: 12094213
[TBL] [Abstract][Full Text] [Related]
24. Animal models of neurological disorders.
Chesselet MF
NeuroRx; 2005 Jul; 2(3):395. PubMed ID: 16389303
[No Abstract] [Full Text] [Related]
25. [Common root for degenerative encephalopathies? Pathophysiologic background for Huntington chorea--amyloid as in Alzheimer disease, Parkinson disease or Creutzfeldt-Jakob disease are detected].
Knauer RH
Fortschr Med; 1998 Mar; 116(7):39-40. PubMed ID: 9562716
[No Abstract] [Full Text] [Related]
26. Presynaptic neuron and postsynaptic dopamine receptor function in long term treatment of Parkinson's disease: a neuroendocrine study.
Agnoli A; Ruggieri S; Baldassarre M; Rocco A; Del Roscio S; D'Urso R; Mearelli S; Falaschi P; Frajese G
Prog Clin Biol Res; 1980; 39():215-24. PubMed ID: 6773067
[No Abstract] [Full Text] [Related]
27. Management of upper extremity dysfunction in people with Parkinson disease and Huntington disease: facilitating outcomes across the disease lifespan.
Quinn L; Busse M; Dal Bello-Haas V
J Hand Ther; 2013; 26(2):148-54; quiz 155. PubMed ID: 23231827
[TBL] [Abstract][Full Text] [Related]
28. Genetics of neurological disorders.
Faghihi MA; Mottagui-Tabar S; Wahlestedt C
Expert Rev Mol Diagn; 2004 May; 4(3):317-32. PubMed ID: 15137899
[TBL] [Abstract][Full Text] [Related]
29. Neurological application of MEG.
Mäkelä JP
Electroencephalogr Clin Neurophysiol Suppl; 1996; 47():343-55. PubMed ID: 9335997
[No Abstract] [Full Text] [Related]
30. [Parkinson-plus-syndromes].
Nacimiento W
Fortschr Neurol Psychiatr; 2006 Mar; 74(3):165-78; quiz 179-80. PubMed ID: 16528643
[No Abstract] [Full Text] [Related]
31. [Potentialization of the action of tl-dopa on the secretion of growth hormone].
Pombo M; Paz M
Arch Fr Pediatr; 1976; 33(7):714-5. PubMed ID: 999443
[No Abstract] [Full Text] [Related]
32. Visual evoked potentials and spatiotemporal contrast sensitivity changes in idiopathic Parkinson's disease and multiple system atrophy.
Delalande I; Destée A; Hache JC; Forzy G; Bughin M; Benhadjali J
Adv Neurol; 1996; 69():319-25. PubMed ID: 8615146
[No Abstract] [Full Text] [Related]
33. Brain catecholamines and neurological disease.
Wurtman RJ; Moskowitz MA
Trans Am Neurol Assoc; 1974; 99():149-59. PubMed ID: 4282535
[No Abstract] [Full Text] [Related]
34. [Saccadic eye movements in extrapyramidal disorders and particularly in Huntington's disease].
Roig C
Neurologia; 2001 Feb; 16(2):57-62. PubMed ID: 11257930
[No Abstract] [Full Text] [Related]
35. The current model of basal ganglia organization under scrutiny.
Parent A; Cicchetti F
Mov Disord; 1998 Mar; 13(2):199-202. PubMed ID: 9539330
[No Abstract] [Full Text] [Related]
36. [Gait disorders - foreword].
Azulay JP; Defebvre L
Rev Neurol (Paris); 2010 Feb; 166(2):141. PubMed ID: 19811799
[No Abstract] [Full Text] [Related]
37. The ability of grafted human sympathetic neurons to synthesize and store dopamine: a potential mechanism for the clinical effect of sympathetic neuron autografts in patients with Parkinson's disease.
Nakao N; Shintani-Mizushima A; Kakishita K; Itakura T
Exp Neurol; 2004 Jul; 188(1):65-73. PubMed ID: 15191803
[TBL] [Abstract][Full Text] [Related]
38. Dopamine and human information processing: a reaction-time analysis of the effect of levodopa in healthy subjects.
Rihet P; Possamaï CA; Micallef-Roll J; Blin O; Hasbroucq T
Psychopharmacology (Berl); 2002 Aug; 163(1):62-7. PubMed ID: 12185401
[TBL] [Abstract][Full Text] [Related]
39. [Basal ganglia disease. Functional neuroanatomy and therapeutic perspectives].
Ostergaard K; Sunde NA; Dupont E
Ugeskr Laeger; 2000 Oct; 162(41):5480-3. PubMed ID: 11068522
[No Abstract] [Full Text] [Related]
40. Treating motor fluctuations with controlled-release levodopa preparations.
Koller WC; Pahwa R
Neurology; 1994 Jul; 44(7 Suppl 6):S23-8. PubMed ID: 8047257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
